166 related articles for article (PubMed ID: 22722526)
1. The development and acceptance of a simple tool to aid IRB compliance.
Vulcano DM
Qual Manag Health Care; 2012; 21(3):203-8. PubMed ID: 22722526
[TBL] [Abstract][Full Text] [Related]
2. A study of warning letters issued to institutional review boards by the United States Food and Drug Administration.
Bramstedt KA; Kassimatis K
Clin Invest Med; 2004 Dec; 27(6):316-23. PubMed ID: 15675112
[TBL] [Abstract][Full Text] [Related]
3. Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.
Ernst AA; Fish S
Acad Emerg Med; 2005 Nov; 12(11):1050-5. PubMed ID: 16264073
[TBL] [Abstract][Full Text] [Related]
4. The ins and outs of independent IRBs.
Lis JM; Murray MG
J Health Life Sci Law; 2008 Oct; 2(1):73, 75-122. PubMed ID: 19004298
[TBL] [Abstract][Full Text] [Related]
5. Frustrations in benchmarking IRBs: reflections after analyzing the United States' IRB registration database.
Vulcano DM
J Empir Res Hum Res Ethics; 2012 Apr; 7(2):34-6. PubMed ID: 22565581
[TBL] [Abstract][Full Text] [Related]
6. Informed consent for research on stored blood and tissue samples: a survey of institutional review board practices.
White MT; Gamm J
Account Res; 2002; 9(1):1-16. PubMed ID: 12705242
[TBL] [Abstract][Full Text] [Related]
7. Practice-based research network studies and institutional review boards: two new issues.
Yawn BP; Graham DG; Bertram SL; Kurland MJ; Dietrich AJ; Wollan PC; Brandt EC; Huff JM; Pace WD
J Am Board Fam Med; 2009; 22(4):453-60. PubMed ID: 19587261
[TBL] [Abstract][Full Text] [Related]
8. Clinician educators' experiences with institutional review boards: results of a national survey.
Dyrbye LN; Thomas MR; Papp KK; Durning SJ
Acad Med; 2008 Jun; 83(6):590-5. PubMed ID: 18520468
[TBL] [Abstract][Full Text] [Related]
9. Is compliance a professional virtue of researchers? Reflections on promoting the responsible conduct of research.
DuBois JM
Ethics Behav; 2004; 14(4):383-95. PubMed ID: 16625734
[TBL] [Abstract][Full Text] [Related]
10. FDA seeks tighter controls over research with human subjects.
Hershey N; Miller RD
Hosp Med Staff; 1978 Dec; 7(12):1-7. PubMed ID: 10239337
[TBL] [Abstract][Full Text] [Related]
11. Anonymous self-evaluation of performance by ethics board members: a pilot study.
Feldman JA; Rebholz CM
J Empir Res Hum Res Ethics; 2009 Mar; 4(1):63-9. PubMed ID: 19382879
[TBL] [Abstract][Full Text] [Related]
12. FDA overview and current challenges in regulation of human subject protection. Food and Drug Administration.
Nightingale SL
J Int Assoc Physicians AIDS Care; 1997 Jan; 3(1):24-6. PubMed ID: 11363959
[TBL] [Abstract][Full Text] [Related]
13. Use of central institutional review boards for multicenter clinical trials in the United States: a review of the literature.
Check DK; Weinfurt KP; Dombeck CB; Kramer JM; Flynn KE
Clin Trials; 2013 Aug; 10(4):560-7. PubMed ID: 23666951
[TBL] [Abstract][Full Text] [Related]
14. Enhancing communication among data monitoring committees and institutional review boards.
Taylor HA; Chaisson L; Sugarman J
Clin Trials; 2008; 5(3):277-82. PubMed ID: 18559418
[TBL] [Abstract][Full Text] [Related]
15. A study of warning letters issued to clinical investigators and institutional review boards by the United States Food and Drug Administration.
Gogtay NJ; Doshi BM; Kannan S; Thatte U
Indian J Med Ethics; 2011; 8(4):211-4. PubMed ID: 22106658
[TBL] [Abstract][Full Text] [Related]
16. Institutional review board guidance on pediatric research: missed opportunities.
Wolf LE; Zandecki J; Lo B
J Pediatr; 2005 Jul; 147(1):84-9. PubMed ID: 16027701
[TBL] [Abstract][Full Text] [Related]
17. How do IRB members make decisions? A review and research agenda.
Pritchard IA
J Empir Res Hum Res Ethics; 2011 Jun; 6(2):31-46. PubMed ID: 21680975
[TBL] [Abstract][Full Text] [Related]
18. Medical education research and IRB review: an analysis and comparison of the IRB review process at six institutions.
Dyrbye LN; Thomas MR; Mechaber AJ; Eacker A; Harper W; Massie FS; Power DV; Shanafelt TD
Acad Med; 2007 Jul; 82(7):654-60. PubMed ID: 17595560
[TBL] [Abstract][Full Text] [Related]
19. Protection of human subjects; standards for institutional review boards for clinical investigations--Food and Drug Administration. Final rule.
Fed Regist; 1981 Jan; 46(17 pt 2):8958-79. PubMed ID: 10249529
[TBL] [Abstract][Full Text] [Related]
20. Federal commissions and local IRBs.
Yesley MS
Hastings Cent Rep; 1983 Oct; 13(5):11-2. PubMed ID: 6643032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
